[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Analgesics in Latvia

October 2024 | | ID: AB11ABC90D5EN
Euromonitor International Ltd

US$ 1,075.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Consumer demand for analgesics is returning to more normal levels as Latvia recovers from the COVID-19 pandemic. The strong growth rates during the pandemic were driven by health concerns and uncertainty, as well as the surge in viral illnesses affecting consumers. Since 2023, sales of analgesics have declined as demand patterns return to normality and consumers switch to cheaper options. In the first half of 2024, seasonal cold and flu levels were way below expectation, and this dampened demand...

Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Analgesics in Latvia
Euromonitor International
October 2024

LIST OF CONTENTS AND TABLES

ANALGESICS IN LATVIA
KEY DATA FINDINGS

2024 DEVELOPMENTS

Retail volume sales fall after pandemic highs
Rising popularity of generic brands drives price competition in analgesics
Topical analgesics remain a popular choice
PROSPECTS AND OPPORTUNITIES
Growing pressure from lower-cost alternatives
Topical analgesics poised for solid growth
Innovation needed as analgesics faces saturation
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2019-2024
Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN LATVIA
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture

2024 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications